{"output": [["Amgen", "COMP", "Announce", "XGEVA", "PRODUCT"], ["XGEVA", "PRODUCT", "Has", "FDA Approval", "EVENT"], ["XGEVA", "PRODUCT", "Operate_In", "Multiple Myeloma Treatment", "SECTOR"], ["Multiple Myeloma", "GPE", "Impact", "Bone Metastases", "CONCEPT"], ["XGEVA", "PRODUCT", "Control", "Skeletal-related Events", "CONCEPT"], ["XGEVA", "PRODUCT", "Relate_To", "Bisphosphonates", "COMP"], ["Amgen", "COMP", "Invests_In", "Clinical Trials", "EVENT"], ["482 Study", "EVENT", "Involve", "XGEVA", "PRODUCT"], ["482 Study", "EVENT", "Involve", "Zoledronic Acid", "PRODUCT"], ["XGEVA", "PRODUCT", "Positive_Impact_On", "Overall Survival", "ECON_INDICATOR"], ["XGEVA", "PRODUCT", "Positive_Impact_On", "Progression-free Survival", "ECON_INDICATOR"]], "published": "2018-01-05T17:00:00.000+02:00"}